XML 51 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION
6 Months Ended
Aug. 31, 2014
STOCK-BASED COMPENSATION [Abstract]  
STOCK-BASED COMPENSATION

NOTE 8 – STOCK-BASED COMPENSATION 

    

Stock-based compensation expense is included in the following captions of the unaudited consolidated income statements (in thousands):

      Three Months Ended   Six Months Ended
      August 31,   August 31,
      2014      2013      2014      2013
Cost of revenues     $ 58            $ 42              $ 110            $ 81  
Research and development       148       122       283       232  
Selling       126       87       239       158  
General and administrative       604       439       1,124       850  
      $ 936     $ 690     $ 1,756     $ 1,321  

    

Changes in the Company's outstanding stock options during the six months ended August 31, 2014 were as follows (options in thousands):

          Weighted  
    Number of   Average  
    Options   Exercise Price  
Outstanding at February 28, 2014     1,093          $ 5.04  
Granted     61     17.47  
Exercised     (111 )   4.89  
Forfeited or expired     (2 )   7.53  
Outstanding at August 31, 2014     1,041   $ 5.78  
Exercisable at August 31, 2014     867   $ 4.55  

    

Changes in the Company's outstanding restricted stock shares and restricted stock units (“RSUs”) during the six months ended August 31, 2014 were as follows (shares and RSUs in thousands):

          Weighted  
    Number of   Average Grant  
    Shares and   Date Fair  
    RSUs   Value  
Outstanding at February 28, 2014     1,024         $ 8.02  
Granted     329     17.86  
Vested     (459 )   5.98  
Forfeited     (17 )   10.30  
Outstanding at August 31, 2014     877   $ 12.74  

     During the six months ended August 31, 2014, the Company retained 171,256 shares of the vested restricted stock and RSUs to satisfy the minimum required statutory amount of employee withholding taxes.

     As of August 31, 2014, there was $11.9 million of total unrecognized stock-based compensation cost related to nonvested stock options, restricted stock and RSUs that is expected to be recognized as an expense over a weighted-average remaining vesting period of 3.1 years.